Literature DB >> 21895635

BRCA1 and BRCA2 mutations among familial breast cancer patients from Costa Rica.

G A Gutiérrez Espeleta1, M Llacuachaqui, L García-Jiménez, M Aguilar Herrera, K Loáiciga Vega, A Ortiz, R Royer, S Li, S A Narod.   

Abstract

The contribution of mutations in BRCA1 and BRCA2 genes to the burden of breast cancer in Costa Rica has not been studied. We estimated the frequency of BRCA mutations among 111 Costa Rican women with breast cancer and a family history of breast cancer. These women were mainly from the metropolitan area of San José. A detailed family history was obtained from each patient and a blood sample was processed for DNA extraction. Mutations in BRCA1 and BRCA2 were sought using a combination of techniques and all mutations were confirmed by direct sequencing. Four different mutations were identified in five patients (four in BRCA2 and one in BRCA1) representing 4.5% of the total. Two unrelated patients were found to have a BRCA2 5531delTT mutation. Other BRCA2 mutations included C5507G and 6174delT. Only one BRCA1 mutation was found (C3522T). The family with the BRCA1 mutation had five cases of gastric cancer. Families with BRCA2 mutations were also reported to have cases of gastric and prostate cancers; however, the full range of cancers associated with BRCA1 and BRCA2 mutations in Costa Rica has not yet been established.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21895635     DOI: 10.1111/j.1399-0004.2011.01774.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  14 in total

Review 1.  Mutations in context: implications of BRCA testing in diverse populations.

Authors:  Gabriela E S Felix; Yonglan Zheng; Olufunmilayo I Olopade
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

2.  Genomic Disparities in Breast Cancer Among Latinas.

Authors:  Filipa Lynce; Kristi D Graves; Lina Jandorf; Charite Ricker; Eida Castro; Laura Moreno; Bianca Augusto; Laura Fejerman; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

Review 3.  Familial Gastric Cancers.

Authors:  Namrata Setia; Jeffrey W Clark; Dan G Duda; Theodore S Hong; Eunice L Kwak; John T Mullen; Gregory Y Lauwers
Journal:  Oncologist       Date:  2015-09-30

4.  The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer.

Authors:  C Villarreal-Garza; J N Weitzel; M Llacuachaqui; E Sifuentes; M C Magallanes-Hoyos; L Gallardo; R M Alvarez-Gómez; J Herzog; D Castillo; R Royer; Mohammad Akbari; F Lara-Medina; L A Herrera; A Mohar; S A Narod
Journal:  Breast Cancer Res Treat       Date:  2015-02-26       Impact factor: 4.872

Review 5.  Genetic Cancer Risk Assessment for Breast Cancer in Latin America.

Authors:  Yanin Chavarri-Guerra; Kathleen Reilly Blazer; Jeffrey Nelson Weitzel
Journal:  Rev Invest Clin       Date:  2017 Mar-Apr       Impact factor: 1.451

6.  Evidence for predictive role of BRCA1 and bTUBIII in gastric cancer.

Authors:  Vladimir M Moiseyenko; Nikita M Volkov; Evgeny N Suspistin; Grigoriy A Yanus; Aglaya G Iyevleva; Ekatherina Sh Kuligina; Alexandr V Togo; Alexandr V Kornilov; Alexandr O Ivantsov; Evgeny N Imyanitov
Journal:  Med Oncol       Date:  2013-03-27       Impact factor: 3.064

Review 7.  Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.

Authors:  Carlos Andrés Ossa; Diana Torres
Journal:  Oncologist       Date:  2016-06-10

8.  Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.

Authors:  Felipe Vaca-Paniagua; Rosa María Alvarez-Gomez; Verónica Fragoso-Ontiveros; Silvia Vidal-Millan; Luis Alonso Herrera; David Cantú; Enrique Bargallo-Rocha; Alejandro Mohar; César López-Camarillo; Carlos Pérez-Plasencia
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

9.  Prevalence and impact of founder mutations in hereditary breast cancer in Latin America.

Authors:  Patricia Ashton-Prolla; Fernando Regla Vargas
Journal:  Genet Mol Biol       Date:  2014-03       Impact factor: 1.771

10.  The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective.

Authors:  Julie Dutil; Volha A Golubeva; Alba L Pacheco-Torres; Hector J Diaz-Zabala; Jaime L Matta; Alvaro N Monteiro
Journal:  Breast Cancer Res Treat       Date:  2015-11-12       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.